Molecular TherapyImmunologyPeer-reviewed journal article
Spatiotemporal atlas of pro-inflammatory (NF-kB) and anti-inflammatory (STAT6) signalling using reporter mice during mRNA vaccination
Electra BrunialtiiD, Alessia PanzeriiD, Nicoletta RizziiD, Alessandro Maria VillaiD, Clara MedaiD, Chiara SfogliariniiD, Stefano PersanoiD, Federico ArlatiiD, Maria L. Guevara LopeziD, Cristina MartelliiD, Gaetano CannavaleiD, Monica Rebecchi, Clara Di VitoiD, Letizia VenturiniiD, Luisa OttobriniiD, Domenico MavilioiD, Susanna Carola FagerholmiD, Saverio MinucciiD, Elisabetta VegetoiD, Paolo CianaiD
Abstract
The immunization process unfolds through a precisely orchestrated sequence of innate and adaptive events across distinct anatomical sites. Although many mechanisms underlying vaccination are well described, most vaccines have been developed empirically, partly due to the lack of tools enabling rapid, organ-specific analysis of immune activation. To address this gap, we developed and validated a novel STAT6 reporter mouse enabling dynamic in vivo whole-body imaging and ex vivo analysis of STAT6-mediated anti-inflammatory signalling, and combined it with an established NF-{kappa}B reporter model to dissect immune activation induced by two LNP-encapsulated mRNA vaccines encoding the same antigen but differing in RNA chemistry (unmodified versus N{superscript 1}-methyl-pseudouridine (m{superscript 1}{Psi})-modified). This dual-reporter system enabled the creation of a spatiotemporal atlas of vaccine-induced signalling, revealing chemistry-dependent immune dynamics and identifying the liver as a predominant early hub for both NF-{kappa}B and STAT6 activity following systemic administration. Integration with antibody measurements demonstrated that early STAT6 activation followed by rapid signal resolution--rather than prolonged NF-{kappa}B-mediated inflammation--correlated with robust humoral responses, suggesting that monitoring NF-{kappa}B and STAT6 dynamics could provide predictive insight into vaccine immunogenicity. Together, these findings establish NF-{kappa}B and STAT6 reporter mice as rapid in vivo screening tools for the early assessment of vaccine immunogenicity and performance. By enabling dynamic, organ-resolved immune profiling, this approach paves the way for more rational, mechanism-driven design of mRNA vaccines and underscores the importance of further investigating the effects of vaccines on the liver, both as a primary LNP target and as an immunologically tolerogenic organ.
- organism: mouse
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 31th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combinational adjuvants delivered by ink-jet potentiate naked mRNA vaccines for robust protection against infectious diseases
Nan Qiao, Junichi Ishikawa, … Satoshi Uchida·bioRxiv·Dec 27, 2025
- mRNA Vaccines Induce Rapid Antibody Responses in Mice
M. Gebre, S. Rauch, … D. H. Barouch·bioRxiv·Nov 1, 2021
- The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
S. Ndeupen, Z. Qin, … B. Z. Igyarto·bioRxiv·Mar 4, 2021
- Systemic trafficking of mRNA lipid nanoparticle vaccine following intramuscular injection generates potent tissue-specific T cell response
Christine Y. Wei, Yining Zhu, … Hai‐Quan Mao·bioRxiv·Apr 21, 2025
- The type I IFN-IL-27 axis promotes mRNA vaccine-induced CD8+ T cell responses
Anthony T. Phan, Emily Aunins, … Christopher A. Hunter·bioRxiv·Jan 16, 2025
- Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
K. O. Saunders, N. Pardi, … B. F. Haynes·bioRxiv·Dec 30, 2020